Anne brings to 23andMe a 10-year background in healthcare investing,
focused primarily on biotechnology companies. Anne left the investing
world with the hope that she could have a positive impact on research and
medicine through 23andMe. From her vantage point, Anne saw a need for
creating a way to generate more information – especially more
personalized information – so that commercial and academic researchers
could better understand and develop new drugs and diagnostics. By
encouraging individuals to access and learn about their own genetic
information, 23andMe will create a common, standardized resource that
has the potential to accelerate drug discovery and bring personalized
medicine to the public. (Plus, getting access to her own genetic information
and understanding it has always been one of Anne’s ambitions.) Anne
graduated from Yale University with a B.S. in biology.
Thomas Goetz is the executive editor of WIRED Magazine, and author of the book The Decision Tree: Taking Control of Your Health in the New Era of Personalized Medicine. Since Goetz joined WIRED in 2001, the magazine has been nominated for 23 National Magazine Awards and has won nine times, including the top award for General Excellence three times. His cover stories at WIRED have been selected for both the Best American Science Writing and the Best Technology Writing anthologies. Goetz holds a Master’s degree in English from the University of Virginia and a Master of Public Health degree from the University of California, Berkeley.
Reach business leaders and technology influencers at the Web 2.0 Summit. Call Kristen Nicasio at (415) 947-6283 or email email@example.com
View a complete list of Web 2.0 Summit contacts.